REGENCELL BIOSCIENCE HOLDING (RGC)

KYG7487R1002 - Common Stock

4.92  -0.31 (-5.93%)

REGENCELL BIOSCIENCE HOLDING

NASDAQ:RGC (12/20/2024, 8:00:01 PM)

4.92

-0.31 (-5.93%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS SubIndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%-172.73%
Sales Q2Q%N/A
CRS7.89
6 Month23%
Overview
Earnings (Last)N/A N/A
Earnings (Next)12-13 2022-12-13/bmo
Ins Owners81.16%
Inst Owners0.06%
Market Cap64.01M
Shares13.01M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts63.4
Short Float %1.8%
Short Ratio0.19
IPO07-16 2021-07-16
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

RGC Daily chart

Company Profile

Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Company Info

REGENCELL BIOSCIENCE HOLDING

11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay

Hong Kong 37918

P: 85221550823

CEO: Yat-Gai Au

Employees: 12

Website: https://www.regencellbioscience.com/

RGC News

News Image2 months ago - Market News VideoMonday Sector Leaders: Vehicle Manufacturers, Drugs
News Image5 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!

News Image5 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them!

News Image5 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!

News Image5 months ago - InvestorPlaceWhat Is Going on With Regencell Bioscience (RGC) Stock Today?

Although Regencell Bioscience likely skyrocketed on its novel traditional therapeutics approach, RGC stock is highly speculative.

RGC Twits

Here you can normally see the latest stock twits on RGC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example